Barely Significant
← all excerpts

Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's.

Saudi Pharm J · 2020 · PMC6950972 · PMID 31920431

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

highly significantp < 0.05actually significant
As for PLCL controls, a highly significant increase, (p < 0.05), in the thee investigated values were reported within 30 min of their incubation in both test media; which could be justified as per the role of PEG in maintaining lipomer stability, both in-vitro ; by reducing aggregation, and in-vivo ; by evading RES and immune system recognition, in addition to preventing protein adsorption, and biofouling ( Moghimi and Szebeni, 2003 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.